Medical devices, healthcare technology and the business of care
510(k) clearance · K252937

ThinkQA 3

Dosisoft SA · Decision date Jun 12, 2026

FDA DECISIONK252937

What did the FDA decide?

FDA records K252937 as a 510(k) premarket notification, with a decision dated Jun 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jun 12, 2026

FDA source record

Regulatory record facts

Identifier
K252937
Regulatory pathway
510(k) premarket notification
Applicant
Dosisoft SA
Product code
IYE
Decision code
SESE
Decision date
Jun 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Accelerator, Linear, Medical.

Applicant
Dosisoft SA
Product code
IYE
FDA device class
2

FDA decision timeline

  1. K252937 received

    Application receipt date recorded by FDA.

  2. K252937 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYE

Product / regulatory recordCompanyPathwayDecision dateSource
Stabilix, LLC510(k) clearanceSep 16, 2026FDA
Radformation, Inc.510(k) clearanceAug 31, 2026FDA
Manteia Technologies Co., Ltd.510(k) clearanceAug 26, 2026FDA
Varian Medical Systems, Inc.510(k) clearanceAug 3, 2026FDA
LUNA 3DK253004
Lap GmbH Laser Applikationen510(k) clearanceJun 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Dosisoft SA

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cachan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records